Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression
Title:
Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression
Author:
Zinonos, I. Labrinidis, A. Liapis, V. Hay, S. Lee, M. Ponomarev, V. Diamond, P. Zannettino, A.C.W. Findlay, D.M. Evdokiou, A.